Raul Rodriguez

Chief Executive Officer at RIGEL PHARMACEUTICALS, INC.

Net worth: 9 M $ as of 30/05/2026

65 year

Health Technology

Consumer Services

Profile

Raul R.
Rodriguez is currently President, Chief Executive Officer & Director at Rigel Pharmaceuticals, Inc. since 2014, with employment at the company starting in 2000.
Formerly, Mr. Rodriguez was Executive Director-Business Development at Scios, Inc. from 1994 to 1997 and Senior VP-Business Development & Operations at Ontogeny, Inc. from 1997 to 2000.
Education includes graduate studies at the University of Illinois, an MBA from Stanford Graduate School of Business, and undergraduate studies at Harvard College.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
RIGEL PHARMACEUTICALS, INC. 1.51%	16/06/2026	279,593 ( 1.51% )	9 M $	30/05/2026

Raul Rodriguez active positions

Companies	Position	Start
RIGEL PHARMACEUTICALS, INC.	Chief Executive Officer	20/11/2014

All active positions of Raul Rodriguez

Former positions of Raul Rodriguez

Companies	Position	End
Ontogeny, Inc. Ontogeny, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological diseases	Chief Operating Officer	29/02/2000
Scios, Inc. Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals	Corporate Officer/Principal	28/02/1997

See the detail of Raul Rodriguez's experience

Training of Raul Rodriguez

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Raul Rodriguez's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Scios, Inc. Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals	Health Technology
Rigel Pharmaceuticals, Inc. Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs	Health Technology
Ontogeny, Inc. Ontogeny, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological diseases	Health Technology
University of Illinois University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stanford Graduate School of Business Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard College Harvard College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services